Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating eribulin in combination with anlotinib for metastatic HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer [Phase 3]
Phase 3 trial update evaluating letrozole for postmenopausal women with hormone receptor-positive breast cancer after prior hormone therapy.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating tocotrienol in combination with neoadjuvant chemotherapy for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update for a study in hormone-receptor positive locally advanced or metastatic breast cancer completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer. [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab (Keytruda) effects on biomarkers in early breast cancer, including triple-negative and hormone rece…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant. [Phase 1]
Phase 1 trial evaluating breast cancer cells in premenopausal and postmenopausal women before and after exposure to tamoxifen or fulvestrant…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases [Phase 2]
Phase 2 trial update of cabozantinib with or without trastuzumab in breast cancer patients with brain metastases has completed with results …
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: PREMs on PROMs in Breast Disease (PREMs_PROMs) [Phase 3]
Phase 3 clinical trial update for PREMs on PROMs in breast disease/ breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating fulvestrant in combination with enzalutamide for ER+/HER2- advanced breast cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer [Phase 4]
Phase 4 trial update on tilmanocept tracing and dynamics in early stage breast cancer, withdrew the study.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation [NA]
A terminated clinical trial investigating non-invasive brain stimulation to reduce breast cancer–related fatigue and improve cognition; resu…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA [Phase 2]
Phase 2 trial results evaluating the combination of T-DM1 (ado-trastuzumab emtansine) and pertuzumab as neoadjuvant therapy for early-stage …
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial evaluating F-627 (Neulasta-controlled) in women with breast cancer undergoing myelotoxic chemotherapy has completed and posted…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases [Phase 2]
Phase 2 trial evaluating bevacizumab, etoposide, and cisplatin followed by whole brain radiotherapy for breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Hypofractionated Radiotherapy in Breast Cancer [NA]
A completed clinical trial update on hypofractionated radiotherapy for breast cancer, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. [Phase 1, Phase 2]
A study evaluating ribociclib in combination with everolimus and exemestane in HR-positive, HER2-negative locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Optoacoustic Images Versus Imagio® Ultrasound [NA]
Clinical trial update comparing Optoacoustic imaging to Imagio ultrasound for breast cancer; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity [Phase 3]
Phase 3 trial evaluating GnRHa to protect ovarian function during chemotherapy-induced gonadotoxicity in breast cancer patients; study compl…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX) [NA]
Completed trial investigating screening and brief interventions for alcohol and tobacco use during breast cancer treatment; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial of sacituzumab govitecan in refractory/relapsed metastatic triple-negative breast cancer has completed; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 [Phase 3]
Phase 3 trial update evaluating doxorubicin and cyclophosphamide plus paclitaxel with or without trastuzumab in node-positive, HER2-overexpr…
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC [Phase 2]
Phase II trial of pembrolizumab with palliative radiotherapy in metastatic breast cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant therapy combining palbociclib, exemestane, trastuzumab, and pyrotinib in ER-positive, HER2-pos…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer [Phase 2]
Phase 2 trial evaluating patient preference and satisfaction with subcutaneous administration of the fixed-dose combination of pertuzumab an…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating MEDI4736 (durvalumab) and tremelimumab in metastatic HER2-negative breast cancer has completed with posted r…